Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adimmune, Biocytogen, Biosenic, Celltrion Healthcare, Chipscreen, Clover, Cue, Essex Bio-Technology, Fatiabgen, Gilead Sciences, Kinnate, Kinnjiu, Liscure, Myeloid, Ono, Ordaōs, Shanghai Henlius, Shenzhen Pregene.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Elekta, Hyperfine, Milestone Scientific.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Beauty Health, Bioventus, Diasorin, Cytek, Egnite, Establishment Labs, Luminex, Nanospot, Prelude, Sophia Genetics, Synergy Laboratories.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Amo, Asklepios, Biophytis, Glaukos, Orchard, PDS, Priothera, Replimune, Springworks.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Amarin, Catalyst, CSL, DMK, GC, Pfizer, Redhill, Sunshine, Tempus, Tevard, Theravance, Vertex.